Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
Your doctor will determine the appropriate schedule based on your specific condition and response
Stacking strategically can make results more noticeable and sustainable
Pernicious anemia occurs when the body lacks intrinsic factor, a protein needed to absorb vitamin B12 from food
Advanced Protocol (Weeks 3-12) For individuals with higher body weight, metabolic resistance, or those seeking maximum metabolic enhancement, an advanced 5-amino-1MQ dosage protocol of 100mg daily may be appropriate
Preparation: We recommend you arrive well-hydrated and have a light meal 12 hours before your appointment